ArticleThe lancet. Diabetes & endocrinology2024

Empagliflozin in chronic kidney disease: nephroprotection is independent of albuminuria, primary kidney disease, and baseline eGFR.

Carmine Zoccali et al.PubMed ↗Publisher ↗

No numbers read from the abstract.